| RDEA-594 sodiuM |
LESINURAD SODIUM |
1151516-14-1 |
| Molidustat(BAY 85-3934) |
MOLIDUSTAT |
1154028-82-6 |
| (2S)-Methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno[3,2-c]pyridin-5(2H,4H,6H)-yl)acetate |
2S-氧氯吡格雷(盐酸盐) |
1147350-75-1 |
| 4-[[[3-(3,4-Dimethoxyphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]benzenesulfonamide |
4-[[[3-(3,4-二甲氧基苯基)咪唑并[1,2-B]哒嗪-6-基]氨基]甲基]苯磺酰胺 |
1012343-93-9 |
| E-7449 |
1140964-99-3 |
1140964-99-3 |
| Ziprasidone D8 |
齐拉西酮-D8 |
1126745-58-1 |
| SR-3306 |
化合物SR-3306 |
1128096-91-2 |
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
| TAK-593 |
1005780-62-0 |
1005780-62-0 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| 3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
MK-8033 |
1001917-37-8 |
| TZ-9 |
1002789-86-7 |
1002789-86-7 |
| PDK1 inhibitor |
PDK1 抑制剂 |
1001409-50-2 |
| PF 04447943 |
PF 4447943 |
1082744-20-4 |
| RO3280 |
RO3280 |
1062243-51-9 |
| Cabotegravir (GSK744, GSK1265744) |
卡博特韦 |
1051375-10-0 |
| Benzenepropanoic acid, 4-[[4-(2-chlorophenyl)-2-thiazolyl]methoxy]-2-methyl- |
4-[[4-(2-氯苯基)-2-噻唑基]甲氧基]-2-甲基苯丙酸 |
1050506-87-0 |
| Acetic acid, 2-[4-[[4-(2-chlorophenyl)-2-thiazolyl]methoxy]-2-methylphenoxy]- |
2-[4-[[4-(2-氯苯基)-2-噻唑基]甲氧基]-2-甲基苯氧基]乙酸 |
1050506-75-6 |
| CTS-1027 |
4-[[[4-(4-氯苯氧基)苯基]磺酰基]甲基]四氢-N-羟基-2H-吡喃-4-甲酰胺 |
193022-04-7 |
| ZM 323881 hydrochloride |
5-[(7-苄氧基喹唑啉-4-基)氨基]-4-氟-2-甲基苯酚盐酸盐 |
193000-39-4 |
